HealthCo Healthcare and Wellness REIT

ASX:HCW Stock Report

Market Cap: AU$423.6m

HealthCo Healthcare and Wellness REIT Valuation

Is HCW undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of HCW when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Fair Value: HCW (A$0.77) is trading below our estimate of fair value (A$1.83)

Significantly Below Fair Value: HCW is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HCW?

Key metric: As HCW is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for HCW. This is calculated by dividing HCW's market cap by their current revenue.
What is HCW's PS Ratio?
PS Ratio7x
SalesAU$60.40m
Market CapAU$423.64m

Price to Sales Ratio vs Peers

How does HCW's PS Ratio compare to its peers?

The above table shows the PS ratio for HCW vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.8x
GDI GDI Property Group
3.9x-0.24%AU$337.4m
CDP Carindale Property Trust
7.3x-7.22%AU$451.7m
DXC Dexus Convenience Retail REIT
7x0.40%AU$389.9m
REP RAM Essential Services Property Fund
5x-5.11%AU$290.6m
HCW HealthCo Healthcare and Wellness REIT
7x4.36%AU$423.6m

Price-To-Sales vs Peers: HCW is expensive based on its Price-To-Sales Ratio (7x) compared to the peer average (5.8x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does HCW's PS Ratio compare vs other companies in the Global Health Care REITs Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
HCW 7.0xIndustry Avg. 6.5xNo. of Companies6PS03.67.210.814.418+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: HCW is expensive based on its Price-To-Sales Ratio (7x) compared to the Global Health Care REITs industry average (6.5x).

Price to Sales Ratio vs Fair Ratio

What is HCW's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HCW PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio7x
Fair PS Ratio3.2x

Price-To-Sales vs Fair Ratio: HCW is expensive based on its Price-To-Sales Ratio (7x) compared to the estimated Fair Price-To-Sales Ratio (3.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HCW forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$0.77
AU$0.90
+17.10%
17.48%AU$1.20AU$0.75n/a6
Jan ’27AU$0.72
AU$0.90
+24.37%
17.48%AU$1.20AU$0.75n/a6
Dec ’26AU$0.83
AU$0.92
+11.33%
17.73%AU$1.20AU$0.75n/a5
Nov ’26AU$0.68
AU$0.92
+35.88%
17.73%AU$1.20AU$0.75n/a5
Oct ’26AU$0.70
AU$0.92
+32.00%
17.73%AU$1.20AU$0.75n/a5
Sep ’26AU$0.76
AU$0.92
+22.38%
17.73%AU$1.20AU$0.75n/a5
Aug ’26AU$0.78
AU$0.98
+26.45%
17.27%AU$1.20AU$0.75n/a5
Jul ’26AU$0.72
AU$1.04
+43.17%
12.18%AU$1.20AU$0.89n/a5
Jun ’26AU$0.89
AU$1.07
+20.00%
15.18%AU$1.30AU$0.89n/a5
May ’26AU$0.85
AU$1.15
+34.27%
12.75%AU$1.35AU$1.00n/a5
Apr ’26AU$0.90
AU$1.15
+28.27%
12.75%AU$1.35AU$1.00n/a5
Mar ’26AU$0.98
AU$1.15
+16.55%
12.75%AU$1.35AU$1.00n/a5
Feb ’26AU$1.01
AU$1.14
+13.63%
13.20%AU$1.35AU$1.00n/a5
Jan ’26AU$1.02
AU$1.28
+25.88%
13.45%AU$1.50AU$1.00AU$0.725
Dec ’25AU$1.14
AU$1.39
+22.17%
8.43%AU$1.51AU$1.20AU$0.835
Nov ’25AU$1.14
AU$1.38
+21.88%
9.43%AU$1.51AU$1.20AU$0.684
Oct ’25AU$1.16
AU$1.41
+21.41%
7.01%AU$1.51AU$1.30AU$0.704
Sep ’25AU$1.22
AU$1.44
+17.69%
5.42%AU$1.51AU$1.32AU$0.764
Aug ’25AU$1.19
AU$1.45
+22.06%
8.09%AU$1.61AU$1.29AU$0.784
Jul ’25AU$1.06
AU$1.49
+40.77%
4.98%AU$1.61AU$1.41AU$0.724
Jun ’25AU$1.13
AU$1.49
+32.63%
4.98%AU$1.61AU$1.41AU$0.894
May ’25AU$1.18
AU$1.51
+27.60%
4.77%AU$1.61AU$1.41AU$0.855
Apr ’25AU$1.27
AU$1.59
+25.49%
5.36%AU$1.70AU$1.45AU$0.905
Mar ’25AU$1.38
AU$1.59
+15.91%
5.36%AU$1.70AU$1.45AU$0.985
Feb ’25AU$1.35
AU$1.64
+21.48%
5.37%AU$1.75AU$1.48AU$1.015
Jan ’25AU$1.47
AU$1.64
+11.57%
5.37%AU$1.75AU$1.48AU$1.025
AU$0.9
Fair Value
14.6% undervalued intrinsic discount
6
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/15 22:42
End of Day Share Price 2026/01/15 00:00
Earnings2025/06/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HealthCo Healthcare and Wellness REIT is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew MacFarlaneBell Potter
Jeffrey PehlGoldman Sachs
Sholto MaconochieJefferies LLC